FI83288C - Multifas kombinationspreparat foer oral prevention. - Google Patents
Multifas kombinationspreparat foer oral prevention. Download PDFInfo
- Publication number
- FI83288C FI83288C FI845065A FI845065A FI83288C FI 83288 C FI83288 C FI 83288C FI 845065 A FI845065 A FI 845065A FI 845065 A FI845065 A FI 845065A FI 83288 C FI83288 C FI 83288C
- Authority
- FI
- Finland
- Prior art keywords
- gestodene
- units
- ethinyl estradiol
- estrogen
- progestogen
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title description 2
- 238000002360 preparation method Methods 0.000 claims abstract description 24
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims abstract description 23
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims abstract description 23
- 229960002568 ethinylestradiol Drugs 0.000 claims abstract description 23
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 claims abstract description 20
- 229960005352 gestodene Drugs 0.000 claims abstract description 20
- 239000000583 progesterone congener Substances 0.000 claims abstract description 20
- 229940011871 estrogen Drugs 0.000 claims abstract description 17
- 239000000262 estrogen Substances 0.000 claims abstract description 17
- 239000008187 granular material Substances 0.000 claims description 18
- 230000002354 daily effect Effects 0.000 description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229920003080 Povidone K 25 Polymers 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960004400 levonorgestrel Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 2
- 239000003433 contraceptive agent Substances 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013066 combination product Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000000819 phase cycle Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833347125 DE3347125A1 (de) | 1983-12-22 | 1983-12-22 | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
| DE3347125 | 1983-12-22 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI845065A0 FI845065A0 (fi) | 1984-12-20 |
| FI845065L FI845065L (fi) | 1985-06-23 |
| FI83288B FI83288B (fi) | 1991-03-15 |
| FI83288C true FI83288C (fi) | 1991-06-25 |
Family
ID=6218183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI845065A FI83288C (fi) | 1983-12-22 | 1984-12-20 | Multifas kombinationspreparat foer oral prevention. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4621079A (OSRAM) |
| EP (1) | EP0148724B1 (OSRAM) |
| JP (1) | JPS60169419A (OSRAM) |
| AT (1) | ATE34665T1 (OSRAM) |
| AU (1) | AU560487B2 (OSRAM) |
| CA (1) | CA1252047A (OSRAM) |
| CY (1) | CY1464A (OSRAM) |
| DE (2) | DE3347125A1 (OSRAM) |
| DK (1) | DK163209C (OSRAM) |
| FI (1) | FI83288C (OSRAM) |
| HK (1) | HK12289A (OSRAM) |
| IL (1) | IL73889A (OSRAM) |
| MY (1) | MY101778A (OSRAM) |
| NO (1) | NO166756C (OSRAM) |
| NZ (1) | NZ210626A (OSRAM) |
| PH (1) | PH23373A (OSRAM) |
| SG (1) | SG72588G (OSRAM) |
| ZA (1) | ZA8410015B (OSRAM) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4921843A (en) * | 1988-10-20 | 1990-05-01 | Pasquale Samuel A | Contraception system and method |
| USRE35724E (en) * | 1982-04-28 | 1998-02-03 | Bio-Technology General Corp. | Contraception system and method |
| US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
| DK174724B1 (da) * | 1986-07-15 | 2003-10-06 | Wyeth Corp | Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet |
| US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| GB2217988B (en) * | 1988-04-11 | 1992-04-01 | Gould Leonard W | Regimen for increasing bone density in humans |
| US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
| US5747480A (en) * | 1996-05-08 | 1998-05-05 | American Home Products Corporation | Oral contraceptive |
| ATE213947T1 (de) * | 1996-06-25 | 2002-03-15 | Akzo Nobel Nv | Progestogen-anti-progestogen therapien |
| US6479475B1 (en) | 1996-07-26 | 2002-11-12 | Wyeth | Oral contraceptive |
| US5858405A (en) * | 1996-07-26 | 1999-01-12 | American Home Products Corporation | Oral contraceptive |
| US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| US6451778B1 (en) | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
| US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
| US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
| US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| DE60006692T2 (de) | 1999-08-31 | 2004-09-23 | Schering Ag | Pharmazeutische kombination von ethinylestradiol und drospirenone als empfängnisverhütendes mittel |
| EP2305267A3 (en) | 1999-08-31 | 2011-08-17 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
| US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
| US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
| US7989436B2 (en) | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
| US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
| EP1622623A4 (en) * | 2003-04-11 | 2009-03-18 | Barr Lab Inc | METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED |
| CN1933873A (zh) * | 2004-03-19 | 2007-03-21 | 沃纳奇尔科特公司 | 延长周期的多相口服避孕方法 |
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| CN101489563A (zh) | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
| NZ587309A (en) * | 2008-02-13 | 2012-09-28 | Bayer Schering Pharma Ag | Wafer film systems for for the delivery of estrogen or progestin |
| EA201001245A1 (ru) * | 2008-02-13 | 2011-04-29 | Байер Шеринг Фарма Акциенгезельшафт | Содержащая эстрадиол система доставки лекарственного средства |
| UY32836A (es) | 2009-08-12 | 2011-03-31 | Bayer Schering Pharma Ag | Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2365103C3 (de) * | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
| DE2431704A1 (de) * | 1974-07-02 | 1976-01-22 | Asche Ag | Stufenkombinationspraeparate per kontrazeption |
| NL8001593A (nl) * | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
| DE3040978A1 (de) * | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
| US4544554A (en) * | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| DE3341638A1 (de) * | 1983-11-17 | 1984-05-03 | Hermann Dr.rer.nat. 8000 München Heßlinger | Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol |
-
1983
- 1983-12-22 DE DE19833347125 patent/DE3347125A1/de not_active Withdrawn
-
1984
- 1984-12-18 AT AT84730146T patent/ATE34665T1/de not_active IP Right Cessation
- 1984-12-18 EP EP84730146A patent/EP0148724B1/de not_active Expired
- 1984-12-18 DE DE8484730146T patent/DE3471589D1/de not_active Expired
- 1984-12-19 NZ NZ210626A patent/NZ210626A/en unknown
- 1984-12-20 FI FI845065A patent/FI83288C/fi active IP Right Grant
- 1984-12-20 JP JP59267602A patent/JPS60169419A/ja active Granted
- 1984-12-20 AU AU37015/84A patent/AU560487B2/en not_active Expired
- 1984-12-21 ZA ZA8410015A patent/ZA8410015B/xx unknown
- 1984-12-21 US US06/685,016 patent/US4621079A/en not_active Expired - Lifetime
- 1984-12-21 NO NO845194A patent/NO166756C/no not_active IP Right Cessation
- 1984-12-21 CA CA000470846A patent/CA1252047A/en not_active Expired
- 1984-12-21 IL IL73889A patent/IL73889A/xx not_active IP Right Cessation
- 1984-12-21 DK DK623684A patent/DK163209C/da active
- 1984-12-21 PH PH31630A patent/PH23373A/en unknown
-
1987
- 1987-09-30 MY MYPI87002624A patent/MY101778A/en unknown
-
1988
- 1988-10-22 SG SG725/88A patent/SG72588G/en unknown
-
1989
- 1989-02-09 HK HK122/89A patent/HK12289A/xx not_active IP Right Cessation
- 1989-07-21 CY CY1464A patent/CY1464A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI845065A0 (fi) | 1984-12-20 |
| AU3701584A (en) | 1985-07-04 |
| NO166756B (no) | 1991-05-27 |
| DK623684A (da) | 1985-06-23 |
| EP0148724A1 (de) | 1985-07-17 |
| US4621079A (en) | 1986-11-04 |
| HK12289A (en) | 1989-02-17 |
| ZA8410015B (en) | 1985-08-28 |
| SG72588G (en) | 1989-05-26 |
| IL73889A (en) | 1988-05-31 |
| CY1464A (en) | 1989-07-21 |
| AU560487B2 (en) | 1987-04-09 |
| NO845194L (no) | 1985-06-24 |
| DE3347125A1 (de) | 1985-07-11 |
| DK163209B (da) | 1992-02-10 |
| JPS60169419A (ja) | 1985-09-02 |
| FI845065L (fi) | 1985-06-23 |
| JPH0569810B2 (OSRAM) | 1993-10-01 |
| PH23373A (en) | 1989-07-14 |
| DK623684D0 (da) | 1984-12-21 |
| NZ210626A (en) | 1988-02-29 |
| CA1252047A (en) | 1989-04-04 |
| DE3471589D1 (en) | 1988-07-07 |
| ATE34665T1 (de) | 1988-06-15 |
| EP0148724B1 (de) | 1988-06-01 |
| MY101778A (en) | 1992-01-17 |
| IL73889A0 (en) | 1985-03-31 |
| NO166756C (no) | 1991-09-04 |
| DK163209C (da) | 1992-06-29 |
| FI83288B (fi) | 1991-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI83288B (fi) | Multifas kombinationspreparat foer oral prevention. | |
| FI72649C (fi) | Gestagen- och estrogenhaltigt preventivmedel av kombinationserie-typ foer oral anvaendning. | |
| KR100186780B1 (ko) | 피임제제 | |
| US4530839A (en) | Triphasic oral contraceptive | |
| FI99083C (fi) | Matalaestrogeenisia oraalisia raskaudenehkäisyvalmisteita | |
| US4544554A (en) | Triphasic oral contraceptive | |
| US4628051A (en) | Triphasic oral contraceptive | |
| US4616006A (en) | Triphasic oral contraceptive | |
| CA1198057A (en) | Method of contraception using peak progestogen dosage | |
| CA2057714C (en) | Progestagen-only contraceptive | |
| KR100352571B1 (ko) | 배합호르몬피임약제 | |
| RU96115196A (ru) | Состав для контрацепции | |
| ZA200106006B (en) | Triphasic oral contraceptive. | |
| RU97118464A (ru) | Фармацевтический комбинированный препарат для гормональной контрацепции | |
| EP1735056B1 (en) | Extended cycle multiphasic oral contraceptive method | |
| EP0322020A1 (en) | Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis | |
| AU2152799A (en) | Progestogen-antiprogestogen regimens | |
| WO1994004156A1 (en) | Antiprogestogen containing contraceptives | |
| WO1999051214A2 (en) | Progestogen-only contraceptive kit | |
| WO2000009136A1 (en) | Progestogen-only contraceptive kit providing good cycle control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: SCHERING AKTIENGESELLSCHAFT |